NASDAQ:PTI - Proteostasis Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$4.81 -0.07 (-1.43 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$4.81
Today's Range$4.72 - $4.97
52-Week Range$1.71 - $10.38
Volume411,682 shs
Average Volume504,609 shs
Market Capitalization$179.08 million
P/E Ratio-2.06
Dividend YieldN/A
Beta-3.33

SEC Filings

Proteostasis Therapeutics (NASDAQ:PTI) SEC Filings

DateFilerForm TypeView
12/04/2018
11:15 PM
Proteostasis Therapeutics (Filer)
Form EFFECT
View Filing
11/28/2018
7:00 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/23/2018
3:02 PM
Proteostasis Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
11/06/2018
3:16 PM
Proteostasis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/05/2018
3:01 PM
GREAT POINT PARTNERS LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G
View Filing
10/26/2018
3:16 PM
BERGER FRANKLIN M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/24/2018
3:28 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/24/2018
3:21 PM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
10/22/2018
8:50 PM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
10/17/2018
3:30 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/03/2018
7:01 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/10/2018
3:21 PM
Proteostasis Therapeutics (Issuer)
Zimmerman Sandra M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
08/08/2018
3:15 PM
Proteostasis Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/26/2018
6:59 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/03/2018
10:44 AM
Proteostasis Therapeutics (Filer)
Form CT ORDER
View Filing
06/19/2018
3:24 PM
BARRETT M JAMES (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/19/2018
3:08 PM
Kelly Jeffery W. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/19/2018
3:07 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/19/2018
3:07 PM
BERGER FRANKLIN M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/15/2018
2:39 PM
1Globe Capital LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G
View Filing
06/06/2018
3:11 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/07/2018
8:05 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/07/2018
8:04 AM
Proteostasis Therapeutics (Filer)
Form DEFA14A
View Filing
04/26/2018
11:15 PM
Proteostasis Therapeutics (Filer)
Form EFFECT
View Filing
04/23/2018
7:06 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/19/2018
4:12 PM
Proteostasis Therapeutics (Filer)
Form DEFA14A
View Filing
04/19/2018
4:09 PM
Proteostasis Therapeutics (Filer)
Form DEF 14A
View Filing
04/19/2018
3:48 PM
Proteostasis Therapeutics (Filer)
Form S-3/A
View Filing
04/17/2018
6:55 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2018
10:03 AM
Proteostasis Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
View Filing
04/06/2018
3:09 PM
Proteostasis Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
04/04/2018
5:42 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/26/2018
6:04 AM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
03/23/2018
4:03 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/23/2018
4:02 PM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
03/19/2018
3:14 PM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
03/14/2018
4:17 PM
Proteostasis Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
6:22 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/09/2018
2:07 PM
Proteostasis Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
View Filing
03/06/2018
3:29 PM
JENNISON ASSOCIATES LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
View Filing
03/05/2018
4:35 PM
Lee Po Shun (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2018
4:34 PM
Proteostasis Therapeutics (Issuer)
Zecevic Marija (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2018
4:33 PM
Munoz Benito (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/05/2018
4:32 PM
Gilmartin Geoffrey S. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/06/2018
8:59 AM
JENNISON ASSOCIATES LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
View Filing
02/05/2018
4:22 PM
Lee Po Shun (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
4:21 PM
Chhabra Meenu (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
4:21 PM
Proteostasis Therapeutics (Issuer)
Zecevic Marija (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
4:20 PM
Boudreau Helen M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
4:19 PM
Gilmartin Geoffrey S. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/05/2018
4:18 PM
Munoz Benito (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
7:31 AM
Proteostasis Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
View Filing
01/08/2018
6:29 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/21/2017
1:57 PM
New Enterprise Associates 12, Limited Partnership (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13D/A
View Filing
12/19/2017
7:56 AM
BARRETT M JAMES (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
7:55 AM
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
NEA 12 GP, LLC (Reporting)
NEA Partners 12, Limited Partnership (Reporting)
New Enterprise Associates 12, Limited Partnership (Reporting)
Proteostasis Therapeutics (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
7:47 AM
Chhabra Meenu (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
7:46 AM
Kelly Jeffery W. (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/19/2017
7:46 AM
BERGER FRANKLIN M (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/18/2017
4:08 PM
Cormorant Asset Management, LLC (Filed by)
Proteostasis Therapeutics (Subject)
Form SC 13G/A
View Filing
12/18/2017
3:03 PM
Chen Bihua (Reporting)
Cormorant Asset Management, LLC (Reporting)
Cormorant Global Healthcare GP, LLC (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Proteostasis Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/15/2017
4:03 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/14/2017
4:00 PM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
12/12/2017
8:33 PM
Proteostasis Therapeutics (Filer)
Form 424B5
View Filing
12/12/2017
5:55 AM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/11/2017
4:26 PM
Proteostasis Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel